Skip to main content
. 2017 Jul 17;4(1):e000154. doi: 10.1136/bmjgast-2017-000154

Table 3.

Interventions and follow-up

Study Rifaximin (N) Event rate (rifaximin) Norfloxacin (N) Event rate (norfloxacin)  p Value
Mostafa et al14 40 0/40 30 5/30 Not defined
Shamseya and Madkour15 43 2/43 6 6/43 0.265
Assem et al16 82 26/82 78 34/78 0.121
Elfert et al17 103 4/103 92 13/92 0.041